Atossa Genetics (ATOS) Announces CAR-T Program in Breast CancerZacks Small Cap Research (press release)On October 2, Atossa Genetics (NASDAQ:ATOS) announced a new program using Chimeric Antigen Receptor Therapy (CAR-T). The company plans to use its pro… Continue reading
WOSU Public Media |
Gene Therapy Offers New Hope To Leukemia Patients At Cincinnati Children’s
WOSU Public Media Gene therapy is showing promise in other formers of cancer. Melanoma and brain cancer are among cancers where immunotherapy is an option. Javier El-Bietar, a bone marrow transplant doctor at Children’s is optimistic about Kymriah for ALL patients. |
OncLive |
Immunotherapy for Management of Stage 3B NSCLC
OncLive Everett Vokes, MD: At this point, we should move on and talk a little bit about earlier stage disease and how therapies are developing. This year, at The European Society for Medical Oncology (ESMO) 2017 Congress, in particular, we’ve received new … |
|
Immunotherapy in Liver Cancer
OncLive Arndt Vogel, MD: Immunotherapy is great, at least we assume that it’s really great. But—and this is unfortunately a “but” that is getting bigger and bigger. Actually, we have seen very promising data with nivolumab. And I think patients who respond to … |
OutSourcing-Pharma.com |
FDA aims to better understand immunotherapy in the ‘real world’
OutSourcing-Pharma.com However, following FDA-approval of immunotherapies to treat various cancer, Kush explained the agency “wishes to better understand the safety effects of such drugs in the ‘real world,’ in addition to safety data from clinical trials.” To do so, the US … |